ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
This study is currently recruiting participants.
Verified May 2013 by GlaxoSmithKline
Sponsor:
GlaxoSmithKline
Collaborators:
North Central Cancer Treatment Group
Breast International Group
NCIC Clinical Trials Group
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00490139
First received: June 20, 2007
Last updated: May 14, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2018 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |